Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
British Journal of Pharmacology
|
January 28, 2004
Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's disease
Sylvie Toulmond, Keith Tang, Yves Bureau, et al.
ACS Medicinal Chemistry Letters
|
September 17, 2021
Utilization of Metabolite Identification and Structural Data to Guide Design of Low-Dose IDO1 Inhibitors
Brett Hopkins, Hongjun Zhang, Indu Bharathan, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 27, 2004
Discovery of novel aspartyl ketone dipeptides as potent and selective caspase-3 inhibitors
Yongxin Han, André Giroux, Erich L Grimm, et al.
ACS Medicinal Chemistry Letters
|
August 25, 2020
Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors
Qinglin Pu, Hongjun Zhang, Liangqin Guo, et al.
Journal of Medicinal Chemistry
|
July 24, 2008
Identification of 4-aminopyrazolylpyrimidines as potent inhibitors of Trk kinases
Tao Wang, Michelle L Lamb, David A Scott, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 31, 2011
Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of pyridone-substituted piperidines
Austin Chen, Louis-Charles Campeau, Elizabeth Cauchon, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 7, 2011
Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of tertiary alcohol-bearing piperidines
Austin Chen, Elizabeth Cauchon, Amandine Chefson, et al.
ACS Medicinal Chemistry Letters
|
November 22, 2019
Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy
Hongjun Zhang, Kun Liu, Qinglin Pu, et al.
Oncoimmunology
|
April 2, 2021
Combination of EP<sub>4</sub> antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cells
Yun Wang, Long Cui, Peter Georgiev, et al.
ACS Medicinal Chemistry Letters
|
April 16, 2020
Strategic Incorporation of Polarity in Heme-Displacing Inhibitors of Indoleamine-2,3-dioxygenase-1 (IDO1)
Catherine White, Meredeth A McGowan, Hua Zhou, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
British Journal of Pharmacology
|
January 28, 2004
Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's disease
Sylvie Toulmond, Keith Tang, Yves Bureau, et al.
ACS Medicinal Chemistry Letters
|
September 17, 2021
Utilization of Metabolite Identification and Structural Data to Guide Design of Low-Dose IDO1 Inhibitors
Brett Hopkins, Hongjun Zhang, Indu Bharathan, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 27, 2004
Discovery of novel aspartyl ketone dipeptides as potent and selective caspase-3 inhibitors
Yongxin Han, André Giroux, Erich L Grimm, et al.
ACS Medicinal Chemistry Letters
|
August 25, 2020
Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors
Qinglin Pu, Hongjun Zhang, Liangqin Guo, et al.
Journal of Medicinal Chemistry
|
July 24, 2008
Identification of 4-aminopyrazolylpyrimidines as potent inhibitors of Trk kinases
Tao Wang, Michelle L Lamb, David A Scott, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 31, 2011
Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of pyridone-substituted piperidines
Austin Chen, Louis-Charles Campeau, Elizabeth Cauchon, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 7, 2011
Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of tertiary alcohol-bearing piperidines
Austin Chen, Elizabeth Cauchon, Amandine Chefson, et al.
ACS Medicinal Chemistry Letters
|
November 22, 2019
Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy
Hongjun Zhang, Kun Liu, Qinglin Pu, et al.
Oncoimmunology
|
April 2, 2021
Combination of EP<sub>4</sub> antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cells
Yun Wang, Long Cui, Peter Georgiev, et al.
ACS Medicinal Chemistry Letters
|
April 16, 2020
Strategic Incorporation of Polarity in Heme-Displacing Inhibitors of Indoleamine-2,3-dioxygenase-1 (IDO1)
Catherine White, Meredeth A McGowan, Hua Zhou, et al.
Page
of 7